Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
226
Frequently Asked Questions
What is Market Cap of Abeona Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Abeona Therapeutics Inc market cap is $310.51M.
What is the 52-week high for Abeona Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Abeona Therapeutics Inc 52 week high is $7.65 as of September 15, 2026.
What is the 52-week low for Abeona Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Abeona Therapeutics Inc 52 week low is $4.00 as of September 15, 2026.
What is Abeona Therapeutics Inc stock price today?
Abeona Therapeutics Inc stock price today is $5.47.
What was Abeona Therapeutics Inc stock price yesterday?
Abeona Therapeutics Inc stock price yesterday was $5.43.
What is the PE ratio of Abeona Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Abeona Therapeutics Inc's P/E ratio is -4.84.
What is the Price-to-Book ratio of Abeona Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Abeona Therapeutics Inc P/B ratio is 2.4265.
What is the 50-day moving average of Abeona Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Abeona Therapeutics Inc 50-day moving average is $6.39.
How many employees does Abeona Therapeutics Inc have?